Novartis Corporation v. Teva Parenteral Medicines Inc.
1:08-cv-00952
Overview
Parties
Defendant
Teva Parenteral Medicines Inc. Operating Company
Represented By
2 Attorneys ListedBayard, P.A.
Bayard, P.A., 222 Delaware Avenue, Suite 900
Teva Pharmaceuticals USA Inc. Operating Company
Represented By
1 Attorneys ListedBayard, P.A.
Bayard, P.A., 222 Delaware Avenue, Suite 900
Teva Pharmaceutical Industries Ltd. Operating Company
Represented By
1 Attorneys ListedBayard, P.A.
Bayard, P.A., 222 Delaware Avenue, Suite 900
Novartis Corporation Operating Company
Represented By
7 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Novartis Pharmaceuticals Corporation Operating Company
Represented By
1 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US4939130
Substituted alkanediphosphonic acids and pharmaceutical use
|
Filed: 1989-02-27
Issued: 1990-07-03
|
Expired (Term Ended)
+1283d PTA
Expires: 2012-09-02
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
High PTA (+1283 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).